Coronavirus disease 2019 (COVID-19) has spread worldwide determining a dramatic impact on the healthcare system. Aim of this study is to evaluate mid-term clinical impact of COVID-19 on respiratory function.

Acute kidney disease (AKD) and chronic kidney disease (CKD) are highly prevalent among hospitalized patients and they have important metabolic and nutritional consequences. Moreover, in case of kidney replacement therapy the possible impact on nutritional profiles, substrate balance, and nutritional treatment processes cannot be neglected.  

This is the first European study reporting on respiratory follow-up outcomes after SARS CoV-2 infection.

Energy expenditure appears highly variable among critically ill patients and in individual patients during various phases of illness. As a consequence, critically ill patients are at considerable risk of under- or overfeeding during ICU and post-ICU hospital stay, when rough and static estimates are used. The most recent international guidelines recommend regular indirect calorimetry to measure energy expenditure as a proxy for caloric requirement in ICU patients.

This review article summarizes current evidence supporting the role of higher protein intakes, especially during the early phases of nutrition therapy in acute illness, methods for assessing protein requirements, as well as, the currently available high-protein enteral and parenteral nutrition solutions.